lhunath writes: Scientists at the University of Gent exposed the TSLP protein’s function in triggering allergic reactions such as asthma and eczema. The team then developed a protein-based inhibitor used to capture TSLP and prevent its bioactivity as it associates with its natural receptors. Using this method, allergic reactions can be inhibited before they are triggered. The team’s results were recently published in Nature, where they share a vision that their work “will guide therapeutic approaches that manipulate human TSLP-mediated signalling to treat allergic diseases.”
Read more of this story at Slashdot.